Effect of a labile methyl donor on the transformation of 5-demethyltangeretin and the related implication on bioactivity

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 34, 2013, Pages 8090-8097

  Ting, Yuwen ^a   Li, Colin C ^a   Pan, Min Hsiung ^b   Ho, Chi Tang ^a   Huang, Qingrong ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

5 demethyltangeretin; in vitro anti cancer cell proliferation activity; labile methyl donor; lecithin based emulsion; lipolysis; tangeretin; transformation

Indexed keywords

5-DEMETHYLTANGERETIN; IN-VITRO; LABILE METHYL DONOR; LIPOLYSIS; TANGERETIN; TRANSFORMATION;

BIOCHEMISTRY; DISEASES; ENZYMES; FUNCTIONAL GROUPS; LECITHIN;

EMULSIFICATION;

ANTINEOPLASTIC AGENT; DRUG CARRIER; FLAVONE DERIVATIVE; FLAVONOID; TANGERETIN;

ARTICLE; BIOAVAILABILITY; CELL PROLIFERATION; CELL STRAIN HEPG2; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN;

ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CELL PROLIFERATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLAVONES; FLAVONOIDS; HEP G2 CELLS; HUMANS; MOLECULAR STRUCTURE;

EID: 84883318899     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf400562p     Document Type: Article

References (46)

1. Li, S. M.; Pan, M. H.; Lo, C. Y.; Tan, D.; Wang, Y.; Shahidi, F.; Ho, C. T. Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones J. Funct. Foods 2009, 1, 2-12
2. Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Effect of citrus flavonoids on HL-60 cell differentiation Anticancer Res. 1999, 19, 1261-1269
3. Kohno, H.; Yoshitani, S.; Tsukio, Y.; Murakami, A.; Koshimizu, K.; Yano, M.; Tokuda, H.; Nishino, H.; Ohigashi, H.; Tanaka, T. Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats Life Sci. 2001, 69, 901-913
4. Reddel, R. R.; Ke, Y.; Gerwin, B. I.; Mcmenamin, M. G.; Lechner, J. F.; Su, R. T.; Brash, D. E.; Park, J. B.; Rhim, J. S.; Harris, C. C. Transformation of human bronchial epithelial-cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes Cancer Res. 1988, 48, 1904-1909
5. Stoner, G. D.; Kaighn, M. E.; Reddel, R. R.; Resau, J. H.; Bowman, D.; Naito, Z.; Matsukura, N.; You, M.; Galati, A. J.; Harris, C. C. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells Cancer Res. 1991, 51, 365-71
6. Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Antiproliferative activity of flavonoids on several cancer cell lines Biosci., Biotechnol., Biochem. 1999, 63, 896-899
7. Lai, H. C.; Wu, M. J.; Chen, P. Y.; Sheu, T. T.; Chiu, S. P.; Lin, M. H.; Ho, C. T.; Yen, J. H. Neurotrophic effect of citrus 5-hydroxy-3,6,7,8,3′, 4′-hexamethoxyflavone: promotion of neurite outgrowth via cAMP/PKA/CREB pathway in PC12 cells PLoS One 2011, 6, e28280
8. Li, S. M.; Pan, M. H.; Lai, C. S.; Lo, C. Y.; Dushenkov, S.; Ho, C. T. Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines Bioorg. Med. Chem. 2007, 15, 3381-3389
9. Pan, M. H.; Lai, Y. S.; Lai, C. S.; Wang, Y. J.; Li, S. M.; Lo, C. Y.; Dushenkov, S.; Ho, C. T. 5-hydroxy-3,6,7,8,3 ′,4 ′- hexamethoxyflavone induces apoptosis through reactive oxygen species production, growth arrest and DNA damage-inducible gene 153 expression, and caspase activation in human leukemia cells J. Agric. Food Chem. 2007, 55, 5081-5091
10. Qiu, P. J.; Dong, P.; Guan, H. S.; Li, S. M.; Ho, C. T.; Pan, M. H.; McClements, D. J.; Xiao, H. Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells Mol. Nutr. Food Res. 2010, 54, S244-S252
11. Sergeev, I. N.; Li, S. M.; Colby, J.; Ho, C. T.; Dushenkov, S. Polymethoxylated flavones induce Ca2+-mediated apoptosis in breast cancer cells Life Sci. 2006, 80, 245-253
12. Xiao, H.; Yang, C. S.; Li, S.; Jin, H.; Ho, C. T.; Patel, T. Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis Mol. Nutr. Food Res. 2009, 53, 398-406
13. Chopraa, S.; Kohlia, K.; Aroraa, S.; Khara, R. K. In-situ nano-emulsification technique for enhancing oral bioavailability of curcumin and thereby evaluating its anticancer efficacy on human lung adeno-carcinoma epithelial cell line J. Pharm. Res. 2011, 4, 4087-4093
14. Gui, S. Y.; Wu, L.; Peng, D. Y.; Liu, Q. Y.; Yin, B. P.; Shen, J. Z. Preparation and evaluation of a microemulsion for oral delivery of berberine Pharmazie 2008, 63, 516-519
15. Kuo, C. L.; Chi, C. W.; Liu, T. Y. The anti-inflammatory potential of berberine in vitro and in vivo Cancer Lett. 2004, 203, 127-137
16. Li, Y.; Zheng, J.; Xiao, H.; McClements, D. J. Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on polymethoxyflavone crystallization Food Hydrocolloids 2012, 27, 517-528
17. Lin, W.; Hong, J.-L.; Shen, G.; Wu, R. T.; Wang, Y.; Huang, M.-T.; Newmark, H. L.; Huang, Q.; Khor, T. O.; Heimbach, T.; Kong, A.-N. Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition Biopharm. Drug Dispos. 2011, 32, 65-75
18. Shao, B.; Tang, J.; Ji, H.; Liu, H.; Liu, Y.; Zhu, D.; Wu, L. Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems Drug Dev. Ind. Pharm. 2010, 36, 1356-1363
19. Tang, J.-l.; Sun, J.; He, Z.-G. Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs Curr. Drug Ther. 2007, 2, 85-93
20. Wu, W.; Wang, Y.; Que, L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system Eur. J. Pharm. Biopharm. 2006, 63, 288-294
21. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Body distribution of camptothecin solid lipid nanoparticles after oral administration Pharm. Res. 1999, 16, 751-757
22. You, J.; Cui, F.-d.; Li, Q.-p.; Han, X.; Yu, Y.-w.; Yang, M.-s. A novel formulation design about water-insoluble oily drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits Int. J. Pharm. 2005, 288, 315-323
23. Yu, H.; Huang, Q. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions J. Agric. Food Chem. 2012, 60, 5373-5379
24. Zhang, P.; Liu, Y.; Feng, N.; Xu, J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin Int. J. Pharm. 2008, 355, 269-276
25. Yu, H. L.; Shi, K.; Liu, D.; Huang, Q. R. Development of a food-grade organogel with high bioaccessibility and loading of curcuminoids Food Chem. 2012, 131, 48-54
26. McClements, D. J.; Xiao, H. Potential biological fate of ingested nanoemulsions: influence of particle characteristics Food Funct. 2012, 3, 202-220
27. Wang, X. Y.; Jiang, Y.; Wang, Y. W.; Huang, M. T.; Ho, C. T.; Huang, Q. R. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions Food Chem. 2008, 108, 419-424
28. Ting, Y. W.; Xia, Q. Y.; Li, S. M.; Ho, C. T.; Huang, Q. R. Design of high-loading and high-stability viscoelastic emulsions for polymethoxyflavones. Food Res. Int. 2013, DOI: 10.1016/j.foodres.2013.07.047, in press.
29. Wang, Z.; Li, S.; Ferguson, S.; Goodnow, R.; Ho, C. T. Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts J. Sep. Sci. 2008, 31, 30-7
30. Charman, W. N. Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts J. Pharm. Sci. 2000, 89, 967-978
31. Dahan, A.; Hoffman, A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs J. Controlled Release 2008, 129, 1-10
32. Humberstone, A. J.; Charman, W. N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs Adv. Drug Delivery Rev. 1997, 25, 103-128
33. Porter, C. J.; Trevaskis, N. L.; Charman, W. N. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discovery 2007, 6, 231-48
34. Trevaskis, N. L.; Charman, W. N.; Porter, C. J. H. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update Adv. Drug Delivery Rev. 2008, 60, 702-716
35. Nienstedt, W.; Ojanotko, A.; Toivonen, H. Metabolism of progesterone, 17-hydroxyprogesterone and deoxycorticosterone by human small intestine in vitro J. Steroid Biochem. 1980, 13, 1417-20
36. Dahan, A.; Hoffman, A. Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats Pharm. Res. 2006, 23, 2165-2174
37. Cuine, J. F.; Charman, W. N.; Pouton, C. W.; Edwards, G. A.; Porter, C. J. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs Pharm. Res. 2007, 24, 748-57
38. Marchan, R.; Lesjak, M. S.; Stewart, J. D.; Winter, R.; Seeliger, J.; Hengstler, J. G. Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities Cell Cycle 2012, 11, 4499-4506
39. Michel, V.; Bakovic, M. Editorial: choline and brain function Cent. Nerv. Syst. Agents Med. Chem. 2012, 12, 69
40. Niculescu, M. D.; Craciunescu, C. N.; Zeisel, S. H. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains FASEB J. 2006, 20, 43-9
41. Nie, K.; Zhang, Y.; Huang, B.; Wang, L.; Zhao, J.; Huang, Z.; Gan, R. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment Parkinsonism Relat. Disord. 2013, 19, 329-34
42. Rajaie, S.; Esmaillzadeh, A. Dietary choline and betaine intakes and risk of cardiovascular diseases: review of epidemiological evidence ARYA Atheroscler. 2011, 7, 78-86
43. Wu, G.; Zhang, L.; Li, T.; Zuniga, A.; Lopaschuk, G.; Li, L.; Jacobs, R. L.; Vance, D. E. Choline supplementation promotes hepatic insulin resistance in phosphatidylethanolamine N-methyltransferase-deficient mice via increased glucagon action J. Biol. Chem. 2013, 288, 837-47
44. Zeisel, S. H. Nutritional importance of choline for brain development J. Am. Coll. Nutr. 2004, 23, 621S-626S
45. Zeisel, S. H. A brief history of choline Ann. Nutr. Metab. 2012, 61, 254-8
46. Pan, M.-H.; Chen, W.-J.; Lin-Shiau, S.-Y.; Ho, C.-T.; Lin, J.-K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells Carcinogenesis 2002, 23, 1677-1684